- Home
- VIR vs PGNY Comparison
VIR vs PGNY Comparison
Compare VIR & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- PGNY
- Stock Information
- Founded
- VIR 2016
- PGNY 2008
- Country
- VIR United States
- PGNY United States
- Employees
- VIR N/A
- PGNY N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- PGNY Misc Health and Biotechnology Services
- Sector
- VIR Health Care
- PGNY Health Care
- Exchange
- VIR Nasdaq
- PGNY Nasdaq
- Market Cap
- VIR 1.0B
- PGNY 1.2B
- IPO Year
- VIR 2019
- PGNY 2019
- Fundamental
- Price
- VIR $7.47
- PGNY $16.90
- Analyst Decision
- VIR Buy
- PGNY Buy
- Analyst Count
- VIR 5
- PGNY 9
- Target Price
- VIR $36.40
- PGNY $19.17
- AVG Volume (30 Days)
- VIR 1.4M
- PGNY 1.7M
- Earning Date
- VIR 02-20-2025
- PGNY 02-25-2025
- Dividend Yield
- VIR N/A
- PGNY N/A
- EPS Growth
- VIR N/A
- PGNY 17.45
- EPS
- VIR N/A
- PGNY 0.60
- Revenue
- VIR $78,618,000.00
- PGNY $1,138,730,000.00
- Revenue This Year
- VIR N/A
- PGNY $7.20
- Revenue Next Year
- VIR N/A
- PGNY $1.11
- P/E Ratio
- VIR N/A
- PGNY $28.19
- Revenue Growth
- VIR N/A
- PGNY 10.24
- 52 Week Low
- VIR $6.56
- PGNY $13.39
- 52 Week High
- VIR $13.09
- PGNY $42.08
- Technical
- Relative Strength Index (RSI)
- VIR 45.87
- PGNY 66.04
- Support Level
- VIR $7.15
- PGNY $14.32
- Resistance Level
- VIR $7.56
- PGNY $14.61
- Average True Range (ATR)
- VIR 0.40
- PGNY 0.66
- MACD
- VIR -0.02
- PGNY 0.15
- Stochastic Oscillator
- VIR 24.79
- PGNY 89.15
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About PGNY Progyny Inc.
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.